Tucatinib (Tukysa)

tucatinib · Seagen (Seattle Genetics) and Astellas Pharma

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tucatinib (Tukysa), covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Tucatinib Combined with Trastuzumab and TAS-102 for the Treatment of HER2 Positive Metastatic Colorectal Cancer in Molecularly Selected Patients, 3T Study [Phase 2]

See pricing